VCYT
Veracyte Inc
45.40$
-6.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.4% | -54.5% | -43.0% | -33.2% | -14.7% | -2.7% | -8.3% | -14.4% | 2.5% | 12.2% | 16.8% | 26.4% | |
| 3.1% | 4.6% | 5.4% | 5.3% | 4.3% | 3.4% | 6.8% | 8.9% | 8.7% | 7.5% | 5.3% | 4.1% | |
| 9.3% | 11.3% | 9.8% | 9.2% | 6.5% | 8.1% | 11.1% | 10.3% | 9.0% | 9.2% | 8.1% | 8.4% | |
| 0.4% | 11.5% | 10.5% | 9.2% | 6.4% | 8.1% | 13.2% | 12.0% | 9.3% | – | – | – | |
| -2.5% | 1.1% | -9.8% | -7.6% | -0.7% | -4.0% | -0.4% | 1.9% | -5.5% | -1.0% | -4.7% | -0.4% | |
| 5.3% | 12.5% | 6.5% | 2.4% | 2.0% | 2.3% | 2.4% | 2.4% | 2.9% | 2.8% | 2.5% | 1.9% | |
| -23.6% | -13.5% | -6.5% | -1.7% | -2.0% | -35.5% | -3.3% | -336.7% | -9.9% | 4.2% | -12.6% | -1.8% | |
| 24.3% | 0.0% | 0.0% | 0.0% | – | 0.8% | 3.3% | – | 1.1% | – | – | – | |
| -0.3% | -0.3% | 51.0% | 2.9% | 0.0% | -0.8% | -3.3% | -4.1% | -1.1% | -1.9% | – | – | |
| -0.3% | 38.7% | 29.9% | -1.1% | -0.3% | -20.9% | -0.1% | -0.6% | -0.4% | 0.0% | 0.0% | – | |
| 1.1% | 76.2% | 80.4% | -0.3% | 64.7% | 105.7% | 173.3% | 271.7% | 1.2% | 0.8% | 1.1% | -0.8% | |
| -94.8% | 8.2% | 30.9% | -35.2% | 47.9% | 67.6% | 161.8% | -80.2% | -6.4% | 17.3% | 5.2% | 23.9% | |
| -77.7% | -66.9% | -49.5% | -35.7% | -16.7% | -5.0% | -10.7% | -16.9% | -0.3% | 9.5% | 14.3% | 24.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.